Physician profile
Joseph Scott Hooks
NPI 1609486331
$757.70
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.00 · 2022: $332 · 2023: $326 · 2024: $25.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $359.26 | 2022-2023 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $120.80 | 2022-2023 | Farxiga, Tezspire, Symbicort |
| Baxter Healthcare | $78.18 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Astellas Pharma US INC | $75.00 | 2021 | |
| Mylan Specialty L.P. | $58.41 | 2022-2023 | Yupelri |
| Grifols USA, LLC | $21.15 | 2023 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $18.39 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.29 | 2023 | Uptravi |
| Galt Pharmaceuticals, LLC | $9.22 | 2023 | Oravig, Orphengesic Forte |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.